High-Content Phenotypic Profiling in Esophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery. (2020)

First Author: Hughes RE
Attributed to:  UKRMP Hub: The Engineered Cell Environment. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/2472555220917115

PubMed Identifier: 32441181

Publication URI: http://europepmc.org/abstract/MED/32441181

Type: Journal Article/Review

Volume: 25

Parent Publication: SLAS discovery : advancing life sciences R & D

Issue: 7

ISSN: 2472-5552